Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

University of Rochester · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
chronic lymphocytic leukemia (cll), small lymphocytic lymphoma (sll), phase ii, acalabrutinib, rituximab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 895068
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.